The Potential Role of MUC16 (CA125) Biomarker in Lung Cancer: A Magic Biomarker but with AdversityHebatallah M. Saad, Michel De Waard, Ali I. Al‐Gareeb et al.|Diagnostics|2022Cited by 52
Low-dose CT for lung cancer screening in a high-risk population (SUMMIT): a prospective, longitudinal cohort studyAmyn Bhamani, Terry O’Shaughnessy, Neal Navani et al.|The Lancet Oncology|2025Cited by 48